Akihiro Homma - Concepedia

Author

Akihiro Homma

Also Known As

A HOMMA, A Homma, A. HOMMA, A. Homma, AKIHIRO HOMMA, Akihiro HOMMA, Akihiro Homma, Akira Iwaku, Homma, Akihiro, Naomi Kiyota

403

Publications

5.3K

Citations

H-Index

129

Concepts

All Affiliations

Hokkaido University Hokkaido University Hospital Aichi Cancer Center National Cancer Center Hospital East Shizuoka Cancer Center

About

Akihiro Homma is an author at Hokkaido University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	47	1.4K
2	Health Sciences	14	18	420
3	Engineering	4	4	136
4	Language Studies	1	1	22
5	Social Sciences	1	1	12

Akihiro Homma

131

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, The Lancet Oncology Concurrent ChemoradiotherapyNeoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck Cancer	2024	174
Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial Yasuhisa Hasegawa, Kiyoaki Tsukahara, Seiichi Yoshimoto, Journal of Clinical Oncology	2021	131
Superselective high‐dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses Akihiro Homma, Nobuhiko Oridate, Fumiyuki Suzuki, Cancer	2009	125
Pretreatment lymphocyte‐to‐monocyte ratio as an independent prognostic factor for head and neck cancer Satoshi Kano, Akihiro Homma, Hiromitsu Hatakeyama, Head & Neck	2016	117
Surgical complications of salvage total laryngectomy following concurrent chemoradiotherapy Yasushi Furuta, Akihiro Homma, Nobuhiko Oridate, International Journal of Clinical Oncology Surgical OncologyLaryngectomyLarynxSurgerySurgical Complications	2008	92
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02) Makoto Tahara, Naomi Kiyota, Tomoya Yokota, Annals of Oncology	2018	92
Concomitant Weekly Cisplatin and Radiotherapy for Head and Neck Cancer Akihiro Homma, Noboru Inamura, Nobuhiko Oridate, Japanese Journal of Clinical Oncology	2011	91
Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: Assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI Noriyuki Fujima, Daisuke Yoshida, Tomohiro Sakashita, Magnetic Resonance Imaging	2014	75
Platinum-based Chemotherapy Plus Cetuximab for the First-line Treatment of Japanese Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of a Phase II Trial Takayuki Yoshino, Yasuhisa Hasegawa, Shunji Takahashi, Japanese Journal of Clinical Oncology	2013	73
The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies Noriyuki Fujima, Akihiro Homma, Taisuke Harada, Cancer Imaging	2019	73

Page 1